Florida Senate - 2016                        COMMITTEE AMENDMENT
       Bill No. SB 460
       
       
       
       
       
       
                                Ì943584CÎ943584                         
       
                              LEGISLATIVE ACTION                        
                    Senate             .             House              
                                       .                                
                                       .                                
                                       .                                
                                       .                                
                                       .                                
       —————————————————————————————————————————————————————————————————




       —————————————————————————————————————————————————————————————————
       The Committee on Fiscal Policy (Abruzzo) recommended the
       following:
       
    1         Senate Amendment to Amendment (466428) (with directory and
    2  title amendments)
    3  
    4         Delete lines 466 - 533
    5  and insert:
    6         (a)“Dispensing organization” means an organization
    7  approved by the Department of Health under paragraph (10)(d) to
    8  cultivate, process, and dispense cannabis pursuant to this
    9  section.
   10         (c)(b) “Investigational drug, biological product, or
   11  device” means:
   12         1. A drug, biological product, or device that has
   13  successfully completed phase 1 of a clinical trial but has not
   14  been approved for general use by the United States Food and Drug
   15  Administration and remains under investigation in a clinical
   16  trial approved by the United States Food and Drug
   17  Administration; or
   18         2. Cannabis that is manufactured and sold by a dispensing
   19  organization.
   20         (10)(a)Notwithstanding s. 893.13, s. 893.135, s. 893.147,
   21  or any other law, but subject to the requirements of this
   22  section, an eligible patient and the eligible patient’s legal
   23  representative may purchase cannabis from a dispensing
   24  organization and may possess such cannabis for the patient’s
   25  medical use.
   26         (b)Notwithstanding s. 381.986, s. 893.13, s. 893.135, s.
   27  893.147, or any other law, but subject to the requirements of
   28  this section, a dispensing organization and its owners,
   29  managers, and employees may manufacture, possess, sell, deliver,
   30  distribute, dispense, and lawfully dispose of cannabis.
   31         (c)A dispensing organization and its owners, managers, and
   32  employees are not subject to licensure or regulation under
   33  chapter 465 for manufacturing, possessing, selling, delivering,
   34  distributing, dispensing, or lawfully disposing of cannabis.
   35         (d)By October 1, 2016, the Department of Health shall
   36  approve the establishment of 20 additional dispensing
   37  organizations to cultivate, process, and dispense cannabis
   38  pursuant to this section. An applicant for approval as a
   39  dispensing organization must demonstrate that it possesses the
   40  qualifications specified in s. 381.986(5)(b)2.-7 or that it is a
   41  recognized class member of Pigford v. Glickman, 182 F.R.D. 82
   42  (D.D.C. 1999) or In re Black Farmers Litig., 856 F. Supp. 2d 1
   43  (D.D.C. 2011) and a member of the Black Farmers and
   44  Agriculturalists Association.
   45         (e)As used in this subsection, the terms “manufacture,”
   46  “possession,” “deliver,” “distribute,” and “dispense” have the
   47  same meanings as provided in s. 893.02.
   48         (f)The Department of Health may adopt rules to administer
   49  this subsection.
   50  
   51  ====== D I R E C T O R Y  C L A U S E  A M E N D M E N T ======
   52  And the directory clause is amended as follows:
   53         Delete lines 461 - 462
   54  and insert:
   55         Section 2. Paragraphs (a) through (d) of subsection (2) of
   56  section 499.0295, Florida Statutes, are redesignated as
   57  paragraphs (b) through (e), respectively, present paragraph (b)
   58  of that subsection is amended, a new paragraph (a) is added to
   59  that subsection, and subsection (10) is
   60  
   61  ================= T I T L E  A M E N D M E N T ================
   62  And the title is amended as follows:
   63         Delete lines 591 - 604
   64  and insert:
   65         499.0295, F.S.; defining the term “dispensing
   66         organization”; revising the definition of the term
   67         “investigational drug, biological product, or device”;
   68         providing for eligible patients or their legal
   69         representatives to purchase cannabis from dispensing
   70         organizations and possess such cannabis for medical
   71         use; authorizing certain licensed dispensing
   72         organizations to manufacture, possess, sell, deliver,
   73         distribute, dispense, and dispose of cannabis;
   74         exempting dispensing organizations from specified
   75         laws; directing the Department of Health to approve
   76         the establishment of a limited number of dispensing
   77         organizations by a specified date; requiring
   78         applicants for approval as dispensing organizations to
   79         demonstrate they possess certain qualifications;
   80         authorizing the Department of Health to adopt rules;
   81         stating that certain